Market World Digital Therapeutics Market Outlook | Page 2

The market growth is affected by the lack of the effective monetization techniques which are faced by the
application developers. There has been a shortage of the financial earnings which are partially fulfilled by the
advertisements, paid content, and other prominent revenue generation strategies.
Application Insights
Based on the application, the market is classified into diabetes, obesity, cardiovascular diseases, central nervous
system disease, respiratory diseases, smoking cessation, and others. Diabetes accounts for the largest market
share of the application segment followed by other applications. Diabetes causes heavy burden on patients as
well economies on the health front as well as the economic front. For instance, 8.3 % of the U.S. population
suffer from diabetes while 35% of them exhibit prediabetes symptoms. Also diabetes is expected to show the
fastest growth in the application segment due to the high prevalence and incidence of the disease. Digital
management is helpful in the management of the symptoms of diabetes such as polyuria, polydipsia, and
polyphagia. A large number of medical practitioners are using mHealth and have estimated that diabetes would
reach its highest market limit in the next 5 years.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/digital-therapeutics-market
End use insights
Based on end use, the digital therapeutics market is divided into the patients, employers, providers, payers, and
others. Patients are the major consumers of the therapeutic healthcare programs and applications offered by
digital therapeutics. The usage of these services has been attributed due to increasing cognizance and added
benefits offered by digital therapeutics.
Hospitals accounted for the largest market share owing to increased usage of digital therapeutics services for
patients admitted in these settings. The utilization of these services allows affordable and vital healthcare to
patients.
Regional Insights
The digital therapeutics market by region is characterized into North America, Europe, Asia Pacific, Latin
America, and Middle East & Africa. North America is a market dominator in digital therapeutic market. Growing
number of reforms to limit the surge in healthcare expenditure in the country coupled with drive to focus on a
patient-centric healthcare approach is anticipated to be accountable for the same. Furthermore, North America
is a major center of a great amount of digital therapy suppliers. The U.S. has been conveyed to spend about USD